Small group for the study, but sounds promising...suppressing the production of estrogen was part of the program as well...BD
A bone-building drug also may help certain women with early breast cancer, a study shows.
Breast cancer patients who took the drug Zometa, in addition to hormonal therapy, were 35% less likely to relapse than those given placebos, according to a study of 1,800 pre-menopausal women presented Sunday at the annual meeting of the American Society of Clinical Oncology in Chicago.
Bone drug Zometa helps women with early breast cancer - USATODAY.com
0 comments :
Post a Comment